Dietary Supplements

Browse Dietary Supplements Content

CHPA’s President and CEO Scott Melville released the below statement today following the Senate HELP Committee’s Markup of S.4348, the FDA Safety and Landmark Advancement (FDASLA) Act of 2022:

Jun 14, 2022

Join Duffy MacKay, Senior Vice President of Dietary Supplements at CHPA, and George Paraskevakos, Executive Director of the International Probiotics Association to explore the science behind probiotics, why gut health is so important, and what’s next for this growing category.

Jun 13, 2022

Here are the Federal Register notice summary excerpts that might be of interest to you or others within your organization. Please see notices for complete details.

Jun 8, 2022

The Consumer Healthcare Products Association (CHPA) issued a statement from Duffy MacKay, Senior Vice President of Dietary Supplements, regarding a report from the U.S. Centers for Disease Control and Prevention (CDC) on Pediatric Melatonin Ingestions—United States, 2012-2021.

Jun 3, 2022

CHPA’s President and CEO, Scott Melville, released a statement in response to the introduction of the FDA Safety and Landmark Advancement (FDASLA) Act of 2022.

May 27, 2022

Here are the Federal Register notice summary excerpts that might be of interest to you or others within your organization. Please see notices for complete details.

May 25, 2022

CHPA’s President & CEO, Scott Melville, released a statement in response to the FDA Safety and Landmark Advancement (FDASLA) Act of 2022.

May 18, 2022

Filter Results